Skip to main content
Premium Trial:

Request an Annual Quote

USPTO Publishes Two RNAi-Related Patent Applications: Mar 16, 2006


Title: Cell Specific Gene Silencing using Cell-Specific Promoters In Vitro and In Vivo

Number: 20060052327

Filed: Sept. 7, 2005

Lead Inventor: Lin Liu, Oklahoma State University

According to the patent application's abstract, the invention comprises "Cell-specific methods for silencing genes using double-strand inhibitory RNA (iRNA), [as well] as … constructs for carrying out the methods."

Title: Compositions for the Delivery of Therapeutic Agents and Uses Thereof

Number: 20060051405

Filed: July 19, 2005

Lead Inventor: Ian Maclachlan, Protiva Biotherapeutics

The invention "provides drug delivery vehicles comprising polyethylene-lipid conjugates (PEG-lipid), wherein the circulation lifetime and biodistribution of the drug delivery vehicles are regulated by the PEG-lipid," the patent application's abstract states. "More particularly, the present invention provides liposomes, SNALP and SPLP comprising such PEG-lipid conjugates, and methods of using such compositions to selectively target a tumor site or other tissue of interest (e.g., liver, lung, spleen, etc.)."

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.